Progress of 3D Organoid Technology for Preclinical Investigations: Towards Human In Vitro Models
Authors:
- Yingjuan LiuYLYingjuan Liu
- Honglin XuHXHonglin Xu
- Sabu AbrahamSASabu Abraham
- Xin WangXWXin Wang
- Bernard D. KeavneyBKBernard D. Keavney
Open Access
- 21 December 2022
- journal article
- review article
- Published by Scilight Press Pty Ltd in International Journal of Drug Discovery and Pharmacology
- Vol. 1 (1) , 9
Abstract
Review Progress of 3D Organoid Technology for Preclinical Investigations: Towards Human In Vitro Models Yingjuan Liu *, Honglin Xu, Sabu Abraham, Xin Wang, and Bernard D. Keavney* Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, M13 9PT, UK. * Correspondence: yingjuan.liu@manchester.ac.uk (Yingjuan Liu); bernard.keavney@manchester.ac.uk (Bernard D. Keavney) Received: 1 November 2022 Accepted: 24 November 2022 Published: 21 December 2022 Currently, with an increased requirement for new therapeutic strategies, preclinical drug testing or screening platforms have rapidly evolved in recent years. In comparison to traditional 2D cell cultures, 3D organoids or spheroids with or without scaffolds improve the microenvironment of in vitro cultures, advancing the in vitro biological observation and enabling mechanistic studies of drug reactions in the human tissue-like environment. 3D organoids and spheroids are straightforward to produce, and relatively uniform in size and shape. This helps to facilitate high throughput screening requirements. Spheroids and organoids have been applied in anti-cancer drug testing, toxicity evaluations, as well as mechanism studies for variable organ systems, including the intestine, liver, pancreas, brain, and heart. Among 3D cultures of spheroids and organoids, ‘tumour spheroids’ formed by dissociated tumour tissues or cancer cell lines are relatively simple in composition and commonly applied to anticancer drug screening. The ‘healthy organoids’ differentiated from hiPSCs/hESCs are more complex in cell composition, distribution, structure and function with higher similarity to in vivo organs, and have found applications in toxicity tests, personalised medicine, and therapeutic and mechanistic studies. In most cases, the multicellular 3D organoids are more resistant and stable in reaction to stimulations or chemicals in vitro , suggesting more accurate modelling of in vivo responses. Here, we review recent progress in human-origin organoid/spheroid systems and their applications in preclinical studies.Keywords
This publication has 145 references indexed in Scilit:
- High-throughput generation of spheroids using magnetic nanoparticles for three-dimensional cell cultureBiomaterials, 2013
- Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacyJournal of Controlled Release, 2012
- Directed differentiation of human pluripotent stem cells into intestinal tissue in vitroNature, 2010
- Generation and manipulation of magnetic multicellular spheroidsBiomaterials, 2010
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheNature, 2009
- Southern Ocean deep-water carbon export enhanced by natural iron fertilizationNature, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Functional differentiation of alveolar type II epithelial cells in vitro: Effects of cell shape, cell-matrix interactions and cell-cell interactionsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- Liquid-Overlay Culture of Cellular Spheroids1984
- A Multi-component Radiation Survival Curve Using anin VitroTumour ModelInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1970